Cancer often involves the dysregulation of the cell cycle, leading to uncontrolled cell proliferation. Overexpression or hyperactivation of cyclins and CDKs can result in the bypassing of critical cell cycle checkpoints, contributing to oncogenesis. For example, overexpression of Cyclin D1 and Cyclin E has been linked to various cancers, including breast and lung cancer.
